WallStreetZenWallStreetZen

NASDAQ: HUMA
Humacyte Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Humacyte earnings were -$58.7M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest HUMA earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$37.7M, down 196.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HUMA reported annual earnings of -$148.7M, with 34.2% growth. The next HUMA earnings date is Nov 7, 2025.

HUMA earnings history

Current Revenue
$818.0k
Current Earnings
-$58.7M
Current Profit Margin
-7,171.3%

HUMA Return on Equity

Current Company
N/A
Current Industry
-10%
Current Market
30.7%

HUMA undefined

Current Company
-42.4%
Current Industry
-0.2%
HUMA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HUMA announces earnings.

HUMA undefined

Current Company
-40.92%
Current Industry
6.4%
HUMA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HUMA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HUMA-$40.80M-$58.66MN/A-$0.45
TNXP-$79.44M-$81.42MN/A$259.70
FENC-$9.19M-$12.04MN/A-$0.44
EDIT-$235.43M-$236.86MN/A-$2.85
NMRA-$247.95M-$252.09MN/A-$1.57
View Top Biotech Stocks

HUMA earnings dates

Next earnings date
Nov 7, 2025

Humacyte Earnings Reports & History FAQ

What were Humacyte's earnings last quarter?

On HUMA's earnings call on Invalid Date, Humacyte (NASDAQ: HUMA) reported Q2 2025 earnings per share (EPS) of -$0.24, up 50% year over year. Total HUMA earnings for the quarter were -$37.66 million. In the same quarter last year, Humacyte's earnings per share (EPS) was -$0.48.

If you're new to stock investing, here's how to buy Humacyte stock.

When does Humacyte report earnings?

The next HUMA earnings date is Invalid Date. Add HUMA to your watchlist to be reminded of Humacyte's next earnings date.

Is Humacyte profitable or losing money?

As of the last Humacyte earnings report, Humacyte is currently losing money. Humacyte's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$58.66 million, a 58% decrease year over year.

What was HUMA's earnings growth in the past year?

As of Humacyte's earnings date in Invalid Date, Humacyte's earnings has grown year over year. HUMA earnings in the past year totalled -$58.66 million.

What are Humacyte's earnings expectations?

The current EPS estimate for Humacyte's earnings report in Invalid Date is -$0.16.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.